AGM
TARO

Alpine Global Management’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Alpine Global Management’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-8,158
Closed -$308K – 258
2023
Q3 		$308K Buy
+8,158
New +$306K 0.07% 99

Other funds holding TARO

KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
M
Murchinson Toronto, Ontario, Canada $791M AUM 68.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Alpine Global Management's TARO Position: Q4 2023 in Review

Alpine Global Management sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q4 2023, closing a stake of 8,158 shares — an estimated $308K sold.

Alpine Global Management first reported a position in TARO in Q3 2023 and held it in 1 quarter. The position peaked at $308K in Q3 2023. 90 funds tracked by Wall St. Rank hold TARO as of Q4 2023.

  • Alpine Global Management reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q4 2023 after selling out during the quarter.
  • Alpine Global Management sold 8,158 Taro Pharmaceutical Industries Ltd. shares in Q4 2023, an estimated $308K.
  • Alpine Global Management first reported a position in Taro Pharmaceutical Industries Ltd. in Q3 2023 and held it in 1 quarter.
  • Alpine Global Management's Taro Pharmaceutical Industries Ltd. position peaked at $308K in Q3 2023.
  • 90 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q4 2023.

Based on Alpine Global Management's 13F filing for Q4 2023, filed 12 Feb 2024.